Search Results - "Reske, S. N"

Salvage lymph node dissection with adjuvant radiotherapy for nodal recurrence of prostate cancer by Jilg, C A, Rischke, H C, Reske, S N, Henne, K, Grosu, A-L, Weber, W, Drendel, V, Schwardt, M, Jandausch, A, Schultze-Seemann, W

“…We evaluated the impact of salvage lymph node dissection with adjuvant radiotherapy in patients with nodal recurrence of prostate cancer. By default, nodal…”
Get more information

Comparative analysis of brain structure, metabolism, and cognition in myotonic dystrophy 1 and 2 by WEBER, Y. G, ROEBLING, R, LEHMANN-HORN, F, MOTTAGHY, F. M, LERCHE, H, KASSUBEK, J, HOFFMANN, S, ROSENBOHM, A, WOLF, M, STEINBACH, P, JURKAT-ROTT, K, WALTER, H, RESKE, S. N

“…Myotonic dystrophy type 1 and 2 (DM1/DM2) are multisystemic diseases with common cognitive deficits beside the cardinal muscular symptoms. We performed a…”
Get full text

FDG-PET for clinical use. Results of the 3rd German Interdisciplinary Consensus Conference, "Onko-PET III", 21 July and 19 September 2000 by Reske, S N, Kotzerke, J

“…Positron emission tomography (PET) is the most powerful molecular imaging technique currently available for clinical use. Because deranged tumour metabolism is…”
Get full text

Extranodal malignant lymphoma: detection with FDG PET versus CT by Moog, F, Bangerter, M, Diederichs, C G, Guhlmann, A, Merkle, E, Frickhofen, N, Reske, S N

“…To evaluate use of functional imaging with positron emission tomography (PET) versus computed tomography (CT) for detection of extranodal lymphoma spread…”
Get more information

Use of integrated FDG PET/CT imaging in pulmonary carcinoid tumours by KRÜGER, S., BUCK, A. K., BLUMSTEIN, N. M., PAULS, S., SCHELZIG, H., KROPF, C., SCHUMANN, C., MOTTAGHY, F. M., HOMBACH, V., RESKE, S. N.

“… Background.  Integrated positron emission tomography (PET)/computed tomography (CT) scanners have been recently introduced in the diagnostic work‐up of…”
Get full text

18-F-fluorodeoxyglucose-positron emission tomography as a new approach to detect lymphomatous bone marrow by Moog, F, Bangerter, M, Kotzerke, J, Guhlmann, A, Frickhofen, N, Reske, S N

“…Bone marrow involvement in patients with malignant lymphoma is considered a sign of generalized disease with less favorable prognosis. Bone marrow biopsy…”
Get more information

Whole-body 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) for accurate staging of Hodgkin's disease by Bangerter, M., Moog, F., Buchmann, I., Kotzerke, J., Griesshammer, M., Hafner, M., Elsner, K., Frickhofen, N., Reske, S. N., Bergmann, .

“…Background: Staging of Hodgkin's disease (HD) is accomplished by a variety of invasive and non-invasive modalities. This prospective study was undertaken to…”
Get full text

Preoperative Diagnosis of Ovarian Tumors with MR Imaging: Comparison with Transvaginal Sonography, Positron Emission Tomography, and Histologic Findings by Rieber, Andrea, Nussle, Karin, Stohr, Iris, Grab, Dieter, Fenchel, Sabine, Kreienberg, Rolf, Reske, S. N, Brambs, Hans-Juergen

“…Our study evaluated the diagnostic performance of MR imaging compared with that of transvaginal sonography and positron emission tomography (PET) in patients…”
Get full text

Lymphoma: role of whole-body 2-deoxy-2-[F-18]fluoro-D-glucose (FDG) PET in nodal staging by Moog, F, Bangerter, M, Diederichs, C G, Guhlmann, A, Kotzerke, J, Merkle, E, Kolokythas, O, Herrmann, F, Reske, S N

“…To compare 2-deoxy-2-[fluorine-18]fluoro-D-glucose (FDG) positron emission tomography (PET) with computed tomography (CT) in primary nodal staging of malignant…”
Get more information

Chronic osteomyelitis: detection with FDG PET and correlation with histopathologic findings by Guhlmann, A, Brecht-Krauss, D, Suger, G, Glatting, G, Kotzerke, J, Kinzl, L, Reske, S N

“…To evaluate use of positron emission tomography (PET) with 2-(fluorine-18) fluoro-2-deoxy-D-glucose (FDG) in detection of chronic osteomyelitis. Thirty-one…”
Get more information

Intraindividual comparison of [11C]acetate and [11C]choline PET for detection of metastases of prostate cancer by Kotzerke, J, Volkmer, B G, Glatting, G, van den Hoff, J, Gschwend, J E, Messer, P, Reske, S N, Neumaier, B

“…In a pilot trial we investigated whether significant differences in prostate cancer (PCA) imaging would be observed using [(11)C]acetate and [(11)C]choline…”
Get more information

Pericystic Metabolic Activity in Alveolar Echinococcosis: Assessment and Follow-Up by Positron Emission Tomography by Reuter, S., Schirrmeister, H., Kratzer, W., Dreweck, C., Reske, S. N., Kern, P.

“…Information on parasite viability in alveolar echinococcosis (AE) cannot be obtained by conventional imaging techniques. We evaluated the glucose metabolism of…”
Get full text

FDG PET Can Replace Bone Scintigraphy in Primary Staging of Malignant Lymphoma by Moog, Florian, Kotzerke, Jorg, Reske, Sven N

“…Recent studies indicated that 18F-fluorodeoxyglucose (FDG) PET may be more accurate than CT in staging nodal and extranodal malignant lymphoma. The objective…”
Get full text

Experience with carbon-11 choline positron emission tomography in prostate carcinoma by Kotzerke, J, Prang, J, Neumaier, B, Volkmer, B, Guhlmann, A, Kleinschmidt, K, Hautmann, R, Reske, S N

“…We investigated the potential of carbon-11 choline positron emission tomography (PET) for the detection of lymph node and bone metastases in prostate cancer. A…”
Get full text

Fluorine-18 2-deoxy-2-fluoro-D-glucose PET in the preoperative staging of breast cancer: comparison with the standard staging procedures by Schirrmeister, H, Kühn, T, Guhlmann, A, Santjohanser, C, Hörster, T, Nüssle, K, Koretz, K, Glatting, G, Rieber, A, Kreienberg, R, Buck, A C, Reske, S N

“…The present study compared the diagnostic accuracy of fluorine-18 2-deoxy-2-fluoro-D-glucose positron emission tomography (FDG-PET) with conventional staging…”
Get full text

Early Detection and Accurate Description of Extent of Metastatic Bone Disease in Breast Cancer With Fluoride Ion and Positron Emission Tomography by SCHIRRMEISTER, H, GUHLMANN, A, TRÄGER, H, NEUMAIER, B, DIEDERICHS, C, RESKE, S. N, KOTZERKE, J, SANTJOHANSER, C, KÜHN, T, KREIENBERG, R, MESSER, P, NÜSSLE, K, ELSNER, K, GLATTING, G

“…Previous studies have shown that bone metastases are revealed by magnetic resonance imaging (MRI) or bone marrow scintigraphy several months before they are…”
Get full text

Diagnosis of pancreatic cancer by 2[18F]-fluoro-2-deoxy-D-glucose positron emission tomography by Friess, H, Langhans, J, Ebert, M, Beger, H G, Stollfuss, J, Reske, S N, Büchler, M W

“…The detection of pancreatic cancer or the discrimination between pancreatic cancer and chronic pancreatitis remains an important diagnostic problem. The…”
Get full text

Evaluation of Neoadjuvant Therapy Response of Osteogenic Sarcoma Using FDG PET by Schulte, Michael, Brecht-Krauss, Doris, Werner, Mathias, Hartwig, Erich, Sarkar, Michael R, Keppler, Peter, Kotzerke, Jorg, Guhlmann, Albrecht, Delling, Gunter, Reske, Sven N

“…According to the current treatment protocol of the Cooperative Osteosarcoma Study (COSS), monitoring preoperative chemotherapy response and estimating grade of…”
Get full text

Grading of Tumors and Tumorlike Lesions of Bone: Evaluation by FDG PET by Schulte, Michael, Brecht-Krauss, Doris, Heymer, Berno, Guhlmann, Albrecht, Hartwig, Erich, Sarkar, Michael R, Diederichs, Christoph G, Baer, Alexandra Von, Kotzerke, Jorg, Reske, Sven N

“…Clinical diagnosis of skeletal tumors can be difficult, because such lesions compose a large, heterogeneous group of entities with different biologic…”
Get full text

Fluorine-18-FDG PET and Technetium-99m Antigranulocyte Antibody Scintigraphy in Chronic Osteomyelitis by Guhlmann, Albrecht, Brecht-Krauss, Doris, Suger, Gebhard, Glatting, Gerhard, Kotzerke, Joerg, Kinzl, Lothar, Reske, Sven N

“…The aim of this study was to assess the usefulness of PET with 2-18F-fluoro-2-deoxy-D-glucose (FDG), as compared to immunoscintigraphy (IS) with 99mTc-labeled…”
Get full text